, Tracking Stock Market Picks
Enter Symbol:
Ace (ACE) [hlAlert]

up 113.20 %

Ace (ACE) rated Overweight with price target $68 by Piper Jaffray

Posted on: Friday,  Dec 18, 2009  9:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Ace (NYSE: ACE) on 12/18/2009, when the stock price was $48.61. Since
then, Ace has gained 113.21% as of 01/05/2016's recent price of $103.64.
If you would have followed this Piper Jaffray's recommendation on ACE, you would have gained 113.2% of your investment in 2209 days.

Alcon, Inc. is the world's leading eye care company. Alcon, which has been dedicated to the ophthalmic industry for sixty years, researches, develops, manufactures and markets pharmaceuticals, surgical equipment and devices, contact lens care solutions and other vision care products that treat diseases, disorders and other conditions of the eye. Alcon's majority shareholder is Nestle, S.A., the world's largest food company. All trademarks noted in this release are the property of Alcon, Inc., with the exception of Ciprodex, which is a registered trademark of Bayer AG and licensed to Alcon, Inc. by Bayer Healthcare AG. Moxifloxacin is licensed to Alcon, Inc. by Bayer Healthcare AG.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2009 9:25 AM Buy
48.61 68.00
as of 12/31/2009
1 Week up  20.89 %
1 Month up  24.48 %
3 Months   
1 YTD up  24.48 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy